title: Reply to D.M. Hyman et al and M. Voskoboynik et al.
authors: Mayo Clinic, Rochester, MN ballman@mayo.edu.
authors: Karla V
authors: KV
authors: Ballman
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D017321:Clinical Trials, Phase I as Topic / Q000379:methods*; D006801:Humans; D049451:Nomograms
chemical_list: D000970:Antineoplastic Agents